News
24m
Stockhead on MSNHealth Check: Audeara strives to be ‘the next Cochlear’ in affordable hearing collabHearing minnow Audeara has entered an alliance with Ear Science Institute Australia to develop a more affordable ...
58m
Raw Story on MSN'A plant!' Far-right turns on MAGA mega influencer after major ousterA far-right influencer close to President Donald Trump faces suspicion from some of her fellow conspiracy theorists, who ...
After Loomer targeted surgeon general nominee and Kennedy ally Casey Means, Means’s brother, Calley, suggested that Loomer’s ...
President Trump's executive order to "identify and take appropriate action to correct past misconduct by the Federal Government related to censorship of protected speech" is good enough, DOJ tells ...
Hansa Biosciences’ Idefirix (imlifidase) has reduced patients’ antibodies to a level that allows dosing in patients with ...
SRPT's Q2 report, set to arrive Aug. 6, is likely to have Elevidys updates, restructuring plans and sales outlook in sharp investor focus.
Swedish biotech Hansa Biopharma on Friday released encouraging top-line results from three patients with Duchenne muscular ...
CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of ...
Sarepta and Capricor learned of key regulatory decisions from the media and investors, and Duchenne muscular dystrophy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results